LYB FY2025 SEC EDGAR DEF 14A #27 of 168 in industry

LyondellBasell Industries N.V. CEO pay ratio

The CEO earned $110K in FY2025 against median worker pay of $110,140 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
P7
Filing date
2026-04-10
Industry
Chemicals & Pharmaceuticals
Industry rank
#27/168

Data updated August 2026

Subscribe to LyondellBasell Industries N.V. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
141:1
Moderate (Scale: 0–1000:1)
CEO pay
$110K
Median worker
$110,140

Answer first

LyondellBasell Industries N.V.'s FY2025 CEO total of $110K ranks #1403 of 1,423 complete filings; its 141:1 pay ratio ranks #465. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $110,140. Industry placement uses the FY2025 SIC-28 peer cohort (# 27 of 168, 85th percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1403
$110K of 1,423 FY2025
Ratio rank
#465
141:1 of 1,423
Industry pct
85th
top quartile of industry peers by pay ratio

How LyondellBasell Industries N.V. ranks nationally

LyondellBasell Industries N.V. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$110,140 1st percentile higher than 1% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

LyondellBasell Industries N.V. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($110K) against pay ratio (141:1) for LyondellBasell Industries N.V. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02316647.64633295.26949942.89266590.436.9:165.2:193.5:1121.8:1150.2:1CEO total payPay ratio (CEO : median worker)LyondellBasell Industries N.V., CEO total pay: 110140 · Pay ratio (CEO : median worker): 141:1LyondellBasell Industries N.V.Ocular Therapeutix, Inc, CEO total pay: 247396 · Pay ratio (CEO : median worker): 145:1Ocular Therapeutix, IncFuller H B Co, CEO total pay: 8830569 · Pay ratio (CEO : median worker): 137:1Fuller H B CoAmphastar Pharmaceuticals, Inc., CEO total pay: 8309350 · Pay ratio (CEO : median worker): 135:1Amphastar Pharmaceuticals, Inc.Balchem Corp, CEO total pay: 7894874 · Pay ratio (CEO : median worker): 135:1Balchem Corp
LyondellBasell Industries N.V. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in LyondellBasell Industries N.V.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · LyondellBasell Industries N.V.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
141:1
FY2025
vs prior FY
-11:1
from FY2024 152:1
CEO $ YoY
-1.6%
$110K latest
Filings shown
5
FY2021–2025
LyondellBasell Industries N.V. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $106K - $106,258 179:1 -
2022 $17.6M +16423% $93,846 143:1 -36:1
2023 $106K -99% $106,365 156:1 +13:1
2024 $112K +5.2% $111,898 152:1 -4:1
2025 $110K -1.6% $110,140 141:1 -11:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1489393, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
141:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$110K
Companies in Industry
168
vs. Industry Median
Above
#27 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

LyondellBasell Industries N.V.: MID · MICRO pay ratio

LyondellBasell Industries N.V.'s FY2025 ratio 141:1 ranks #27 of 168 Chemicals & Pharmaceuticals filers (85th percentile). the CEO earned 141× the median employee ($110,140) in FY2025.

Median employee $110,140 (HIGH-MED); MID · MICRO stamps put about 141 median-wage years per CEO year.

CEO Total Pay

$110K

FY2025 Summary Compensation, below median

Pay Ratio

141:1

Near industry median

LyondellBasell Industries N.V. in the higher Chemicals & Pharmaceuticals third

LyondellBasell Industries N.V.'s FY2025 ratio 141:1 ranks #27 of 168 Chemicals & Pharmaceuticals filers (85th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; LyondellBasell Industries N.V.'s $110K CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1403 and ratio rank #465 split - treat 141:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$110K
Median Employee Pay
$110,140
Pay Ratio
141:1
Filing Date
2026-04-10

Company Info

Ticker
LYB
CIK
1489393
Industry
Chemicals & Pharmaceuticals
SIC Code
2860
State
P7
View SEC filings →
SEC EDGAR DEF 14A for CIK 1489393, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. LyondellBasell Industries N.V.'s FY2025 ratio 141:1 ranks #27 of 168 Chemicals & Pharmaceuticals filers (85th percentile).

Read with LyondellBasell Industries N.V.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · MICRO · HIGH-MED.

Pinnacle Financial Partners, Inc. · MICRO

ABS(ceo_total_comp) peer at $109K (Δ $1K lighter vs LyondellBasell Industries N.V.); MODEST · HIGH-MED vs this page's MID · MICRO · HIGH-MED.
Archer-Daniels-Midland Co · MICRO

ABS(ceo_total_comp) peer at $108K (Δ $2K lighter vs LyondellBasell Industries N.V.); STEEP · HIGH-MED vs this page's MID · MICRO · HIGH-MED.
Axogen, Inc. · MICRO

ABS(ceo_total_comp) peer at $113K (Δ $2K heavier vs LyondellBasell Industries N.V.); MID · HIGH-MED vs this page's MID · MICRO · HIGH-MED.
Northrop Grumman Corp /de/ · MICRO

ABS(ceo_total_comp) peer at $113K (Δ $3K heavier vs LyondellBasell Industries N.V.); STEEP · HIGH-MED vs this page's MID · MICRO · HIGH-MED.
Ocular Therapeutix, Inc (SIC 28 pole)

Ocular Therapeutix, Inc stamps MID · MICRO nearest in-SIC by ABS(pay_ratio) to LyondellBasell Industries N.V.'s MID filing.
National dual ranks · #1403/#465

LyondellBasell Industries N.V.'s FY2025 package sits #1403 by CEO dollars and #465 by ratio under MICRO · MID.
Pay-equity trends · MID

LyondellBasell Industries N.V.'s MID · HIGH-MED stamps sit mid-band - pay-equity trends place the ratio against workforce pay.
Data sourced from SEC EDGAR DEF 14A for LyondellBasell Industries N.V. (CIK 1489393), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.